7Lewin M,Carlesso N,Tung CH,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells [J]. Nat Biotechnol,2000,18:410- 414.
8Na K,Park KH,Kim SW,et al. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell (HepG2)[J]. J Controlled Release, 2000,699:225- 236.
9Rao GC,Kumar MS,Mathivanan N,et al. Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems [J]. Pharmazie,2004,59(1):5- 9.
10Mao HQ,Roy K,Troung-Le VL,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis,characterization and transfection efficiency [J]. J Control Release,2001,70:399- 421.
6Seong H A,Chang S K,Hun J S,et al. Efect of recombinant humanbone morphogenetic protein - 4 with carriers in rat calvarial defects. J Periodontol,2003,74 (6) :787.
7Wunder JS, Nielsen TO Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol,2007,8 ( 8 ) : 670.
8AMBRUOSI AYAMAMOTOH, KREUTER J, et al. Body distribution of polysorbate 80 and doxorubicin - loaded [ (14) C ] poly ( buty 1 cyancacrylate) nanopaartieles after j. y. administraction in rats. J Drug Target,2005,1 3(10) :535.
9Sakanoto J,Annapragada A. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv ,2007,4 (4) :359.
10Silva GA . Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surg Neurol. 2007,67 (2) :113.
